Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Clinico-Economical Impact of HTA Implementation on chest pain diagnostic Marker <br />Dott. Antonella Pugliese<br />U.O. E...
WHY AN HTA ON CHEST PAIN DIAGNOSTIC MARKERS PRESCRIPTION? <br />TECHNOLOGY IMPROVEMENT          GUIDELINE MODIFICATION<br ...
METHODOLOGY OF TECHNOLOGY STUDY<br />Technologies<br />Yes,<br />Itshouldbeused<br />No Indication<br />X3= note<br />Clin...
S. Camillo- Forlanini U.O. Formazione e Governo Clinico<br />METHODOLOGY OF TECHNOLOGY STUDY<br />
INTERVENTION  OUTCOME  GRAPHICS<br />
CLINICAL  IMPACT  VERIFICATION  THROUGH STATISTICAL  ANALYSIS<br />CONFIDENCE INTERVAL CONTAINS<br />NUMBER ONE<br />NULL ...
ECONOMICAL ANALYSIS <br />
S. Camillo- Forlanini U.O. Formazione e Governo Clinico<br />APPROPRIATENESS AND <br />ECONOMICAL IMPACT<br />We started f...
Thank you <br />for your attention!<br />Contacts:<br />htacamp@gmail.com<br />
Upcoming SlideShare
Loading in …5
×

Clinico-economical impact of HTA implementation on chest pain diagnostic markers

711 views

Published on

  • Be the first to comment

  • Be the first to like this

Clinico-economical impact of HTA implementation on chest pain diagnostic markers

  1. 1. Clinico-Economical Impact of HTA Implementation on chest pain diagnostic Marker <br />Dott. Antonella Pugliese<br />U.O. Education and Clinical Governance<br />S.Camillo-Forlanini Hospital, Rome, Italy<br />
  2. 2. WHY AN HTA ON CHEST PAIN DIAGNOSTIC MARKERS PRESCRIPTION? <br />TECHNOLOGY IMPROVEMENT GUIDELINE MODIFICATION<br />MAIN DIAGNOSTIC MARKERS OF CHEST PAIN: <br />TROPONIN I and T<br />CK-MB<br />MYOGLOBIN<br />
  3. 3. METHODOLOGY OF TECHNOLOGY STUDY<br />Technologies<br />Yes,<br />Itshouldbeused<br />No Indication<br />X3= note<br />Clinical presentations<br />
  4. 4. S. Camillo- Forlanini U.O. Formazione e Governo Clinico<br />METHODOLOGY OF TECHNOLOGY STUDY<br />
  5. 5. INTERVENTION OUTCOME GRAPHICS<br />
  6. 6. CLINICAL IMPACT VERIFICATION THROUGH STATISTICAL ANALYSIS<br />CONFIDENCE INTERVAL CONTAINS<br />NUMBER ONE<br />NULL HYPOTESIS IS CONFIRMED<br />THERE IS NOT ANY DIFFERENCE BETWEEN BEFORE AND AFTER THE INTERVENTION<br />
  7. 7. ECONOMICAL ANALYSIS <br />
  8. 8. S. Camillo- Forlanini U.O. Formazione e Governo Clinico<br />APPROPRIATENESS AND <br />ECONOMICAL IMPACT<br />We started from an average of about 1100 myoglobin / month / First Aidtests.The intervention led to an inappropriateness reduction of 96.78%.<br />
  9. 9. Thank you <br />for your attention!<br />Contacts:<br />htacamp@gmail.com<br />

×